Clinical Trial Update: Predictive Value of Glycemic Parameters Measured With the FSL Pro iQ During ACS [NA]

View source ↗

Summary

A clinical trial evaluating whether glycemic parameters measured with the FSL Pro iQ CGM during acute coronary syndrome can predict cardiovascular events; curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• FSL Pro iQ

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Acute Coronary Syndrome, Continuous Glucose Measurement | NA | Status: RECRUITING